newsfilter
← Latest News
GlobeNewswire·

BioStem Technologies Commends OIG's Recommendation for CMS to Address ASP Reporting Requirements for Skin Substitute Products

POMPANO BEACH, FLORIDA., March 23, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies ("BioStem" or the "Company") (OTCQB:BSEM), a leading provider of innovative regenerative medicine solutions, is commending the U.S.